Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China · Delayed Price · Currency is CNY 3.170
-0.040 (-1.25%)
Sep 30, 2026, 3:04 PM CST
Huaren Pharmaceutical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,303 | 1,321 | 1,353 | 1,636 | 1,619 | 1,561 |
Revenue Growth | 8.05% | -2.34% | -17.30% | 1.03% | 3.76% | 18.55% |
Gross Profit Gross Profit Growth | 415.77 | 457.04 | 467.55 | 695.83 | 695.9 | 760.15 |
Operating Income Operating Income Growth | 111.99 | 121.33 | 130.05 | 344.84 | 244.58 | 226.64 |
Net Income Net Income Growth | -471.69 | -462.9 | -1,368 | 188.06 | 180.78 | 130.4 |
Earnings Per Share EPS Growth | -0.40 | -0.39 | -1.16 | 0.16 | 0.15 | 0.11 |
EPS Growth | - | - | - | 3.99% | 39.09% | 37.50% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Industrial Industrial Growth | 1,230 | 1,270 | 1,420 | 1,304 | 1,257 |
Business Business Growth | 91.23 | 83.49 | 215.98 | 315.88 | 303.89 |
Total Total Growth | 1,321 | 1,353 | 1,636 | 1,619 | 1,561 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 212.74 | 138.97 | 163.81 | 232.04 | 221.71 | 417.15 |
Total Debt Total Debt Growth | 976.42 | 931.36 | 1,278 | 1,564 | 1,672 | 1,840 |
Net Cash (Debt) Net Cash Growth | -763.68 | -792.39 | -1,114 | -1,332 | -1,450 | -1,423 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.65 | -0.67 | -0.94 | -1.13 | -1.23 | -1.20 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 295.47 | 390.23 | 322.36 | 305.6 | 217.98 | -578.52 |
Capital Expenditures CapEx Growth | -22.62 | -48.98 | -24.69 | -45.86 | -42.33 | -27.86 |
Free Cash Flow Free Cash Flow Growth | 272.85 | 341.25 | 297.67 | 259.74 | 175.65 | -606.38 |
Free Cash Flow Growth | -5.86% | 14.64% | 14.60% | 47.87% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 31.92% | 34.59% | 34.55% | 42.53% | 42.97% | 48.70% |
Operating Margin | 8.60% | 9.18% | 9.61% | 21.07% | 15.10% | 14.52% |
Pretax Margin | -35.53% | -34.73% | -100.19% | 14.09% | 12.71% | 9.63% |
Profit Margin | -36.21% | -35.03% | -101.13% | 11.49% | 11.16% | 8.36% |
FCF Margin | 20.95% | 25.82% | 22.00% | 15.87% | 10.85% | -38.85% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.021 | 0.021 | 0.018 |
Dividend Per Share Growth | 0% | 16.67% | 20.00% |
Dividend Yield | 0.50% | 0.50% | 0.38% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 26.53 | 27.73 | 43.52 |
Forward PE | - | 41.18 | 41.18 | 41.18 | 41.18 | 41.18 |
P/FCF Ratio | 13.74 | 10.91 | 13.98 | 19.21 | 28.54 | - |
PS Ratio | 2.88 | 2.82 | 3.08 | 3.05 | 3.10 | 3.64 |